Skip to main content

Peer Review reports

From: Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)

Original Submission
24 Dec 2019 Submitted Original manuscript
14 Jan 2020 Author responded Author comments - Zhenmei An
Resubmission - Version 2
14 Jan 2020 Submitted Manuscript version 2
23 Jan 2020 Reviewed Reviewer Report - Hidenori Fukuoka
3 Feb 2020 Reviewed Reviewer Report - Hiraku Kameda
27 Feb 2020 Author responded Author comments - Zhenmei An
Resubmission - Version 3
27 Feb 2020 Submitted Manuscript version 3
3 Mar 2020 Reviewed Reviewer Report - Hiraku Kameda
11 Mar 2020 Reviewed Reviewer Report - Hidenori Fukuoka
18 Mar 2020 Author responded Author comments - Zhenmei An
Resubmission - Version 4
18 Mar 2020 Submitted Manuscript version 4
Publishing
23 Mar 2020 Editorially accepted
4 May 2020 Article published 10.1186/s12902-020-0524-7

You can find further information about peer review here.

Back to article page